Sorafenat 200mg tablet
In stock
Description
Sorafenat 200mg tablet, manufactured by Natco Pharma Ltd, is an anti-cancer medication containing Sorafenib (as Sorafenib Tosylate). It is an oral multikinase inhibitor primarily used to treat liver, kidney, and thyroid cancers by blocking the growth of cancer cells and inhibiting tumor angiogenesis (blood vessel formation)
Specifications
| Strength | 200 mg |
|---|---|
| Storage | Store below 30°C |
| Uses | Liver Cancer |
| Main Ingredients | Sorafenib |
| Shelf Life | 2 years |
